Haoxi Health Technology Ltd income statement

In fiscal 2026, Haoxi Health Technology Ltd reported revenue of $54.8m, up 67.1% on the year before, operating income of −$9.7m (a -17.6% margin) and net income of −$9.5m, or −$386.40 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Haoxi Health Technology Ltd: income statement, annual
Fiscal year	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Revenue	16	28	49	33	55
Cost of revenue	16	26	46	32	54
Gross profit	1	2	3	1	1
Research and development	0	0	0	0	0
General and administrative	0	1	1	3	9
Operating income	0	1	2	−2	−10
Interest expense	—	0	0	0	0
Income before tax	0	1	2	4	−9
Income tax	0	0	0	0	0
Net income	0	1	1	4	−10
Diluted EPS	$0.01	$0.43	$1350.77	$3385.53	−$386.40
Diluted shares (average)	50m	2m	—	—	—
EBITDA	0	1	2	−2	−9

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CCEL vs HAO AMS vs HAO HAO vs RDGT

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Haoxi Health Technology Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Haoxi Health Technology Ltd.